Cargando…
Second Malignant Neoplasms Following Radiotherapy
More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhoo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546788/ https://www.ncbi.nlm.nih.gov/pubmed/23249860 http://dx.doi.org/10.3390/ijerph9124744 |
_version_ | 1782256112731422720 |
---|---|
author | Kumar, Sanath |
author_facet | Kumar, Sanath |
author_sort | Kumar, Sanath |
collection | PubMed |
description | More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy. |
format | Online Article Text |
id | pubmed-3546788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-35467882013-02-09 Second Malignant Neoplasms Following Radiotherapy Kumar, Sanath Int J Environ Res Public Health Review More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy. MDPI 2012-12-18 2012-12 /pmc/articles/PMC3546788/ /pubmed/23249860 http://dx.doi.org/10.3390/ijerph9124744 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Kumar, Sanath Second Malignant Neoplasms Following Radiotherapy |
title | Second Malignant Neoplasms Following Radiotherapy |
title_full | Second Malignant Neoplasms Following Radiotherapy |
title_fullStr | Second Malignant Neoplasms Following Radiotherapy |
title_full_unstemmed | Second Malignant Neoplasms Following Radiotherapy |
title_short | Second Malignant Neoplasms Following Radiotherapy |
title_sort | second malignant neoplasms following radiotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546788/ https://www.ncbi.nlm.nih.gov/pubmed/23249860 http://dx.doi.org/10.3390/ijerph9124744 |
work_keys_str_mv | AT kumarsanath secondmalignantneoplasmsfollowingradiotherapy |